Keyphrases
Non-coding RNA (ncRNA)
100%
Clear Cell Renal Cell Carcinoma (ccRCC)
100%
Prognostic Value
100%
Concordance Index
85%
High Risk
28%
Confidence Interval
28%
Quantitative PCR
28%
Patient Management
28%
Patient Treatment
28%
Necrosis
28%
Selection Strategy
28%
Treatment Decisions
28%
Prognostic Biomarker
28%
Long Non-coding RNA (LncRNA)
28%
Management Decisions
28%
Cox Regression Model
28%
Validation Set
28%
Size Grading
28%
Least Absolute Shrinkage
28%
MiRNA Signature
28%
Risk Factors
14%
Hazard Ratio
14%
RNA Sequencing (RNA-seq)
14%
Tumor
14%
Clinical Outcomes
14%
Perioperative Risk
14%
Clinically Significant
14%
Multivariate Analysis
14%
Cancer Types
14%
Clinical Characteristics
14%
Overall Survival
14%
China
14%
Japan
14%
Low Risk
14%
Cancer Genome Atlas
14%
Clinical Management
14%
Disease-free Survival
14%
Training Set
14%
External Validation
14%
Risk Stratification
14%
Statistical Analysis
14%
Clinical Factors
14%
Patient Survival
14%
Clinical Parameters
14%
Individualized Prediction
14%
Disease-specific Survival
14%
Internal Validation
14%
Independent Prognostic Factor
14%
Measurement Analysis
14%
Prognostic Tool
14%
Risk Assessment
14%
RNA-seq Data
14%
Multivariable Cox Regression
14%
Prognostic Accuracy
14%
ATLAS Project
14%
Low-risk Group
14%
Pathologic Factors
14%
Clinical Staging Model
14%
Pathological Parameters
14%
Sample Training
14%
Time-dependent Receiver Operating Characteristic Curve
14%
Prognostic Signature
14%
Reaction Data
14%
Computer Science
Chain Reaction
100%
Selection Operation
100%
Treatment Decision
100%
Validation Set
100%
Clinical Outcome
50%
Characteristic Curve
50%
Independent Set
50%
Training Sample
50%
Multivariate Analysis
50%
Medicine and Dentistry
Clear Cell Renal Cell Carcinoma
100%
Long Untranslated RNA
100%
Biological Marker
28%
RNA Sequencing
28%
Patient Care
28%
Necrosis
28%
Cox Regression Model
28%
Malignant Neoplasm
14%
Hazard Ratio
14%
Overall Survival
14%
Proportional Hazards Model
14%
Tumor
14%
Risk Stratification
14%
The Cancer Genome Atlas
14%
Clinical Management
14%
Disease Free Survival
14%
Prognostic Factor
14%
Quantitative Reverse Transcription Polymerase Chain Reaction
14%
Disease Specific Survival
14%
Outcome Assessment
14%
Low Risk Population
14%
Prognostic Signature
14%
Reverse Transcription Polymerase Chain Reaction
14%
Multivariate Analysis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Renal Cell Carcinoma
100%
Long Untranslated RNA
100%
Malignant Neoplasm
28%
Biological Marker
28%
Necrosis
28%
Overall Survival
14%
Disease Free Survival
14%
Disease Specific Survival
14%
Biochemistry, Genetics and Molecular Biology
Long Non-Coding RNA
100%
RNA Sequencing
28%
Overall Survival
14%
Multivariate Analysis
14%
Disease Free Survival
14%
Disease Specific Survival
14%
Quantitative Reverse Transcription Polymerase Chain Reaction
14%
Low Risk Population
14%
Reverse Transcription Polymerase Chain Reaction
14%